Skip to main content
Stephen Leong, MD, Oncology, Aurora, CO

StephenLeongMD

Oncology Aurora, CO

Gastrointestinal Cancer

Associate Professor, School of Medicine, University of Colorado; Director, Developmental Therapeutic Clinical (Phase I) Program

Dr. Leong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Leong's full profile

Already have an account?

Summary

  • Dr. Stephen Leong is a medical oncologist at the University of Colorado Cancer Center. He received his medical degree from Royal College of Surgeons Ireland and did his medical oncology fellowship at University of Colorado. He specializes in gastrointestinal cancer, adrenal cancer and developmental therapeutics.

Education & Training

  • Harvard Medical School
    Harvard Medical SchoolCertificate in Palliative Care Education and Practice, Palliative Care, 2011 - 2011
  • University of Colorado
    University of ColoradoFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2000 - 2003
  • University College Dublin
    University College DublinMMedScience, Physiology, 1998 - 1999
  • Royal College of Surgeons Ireland
    Royal College of Surgeons IrelandClass of 1997

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2007 - 2023
  • PA State Medical License
    PA State Medical License 2000 - 2004

Awards, Honors, & Recognition

  • Nominated for Golden Stethoscope "Best Role Model" University of Colorado School of Medicine, 2016
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Scholarship, Program in Palliative Care Education and Practice Harvard Medical School, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Books/Book Chapters

Abstracts/Posters

  • Prognostic factors for 90-day mortality in patients with solid malignancies treated on Phase 1 trials sponsored by the Cancer Therapy Evaluation Program (CTEP) of the ...
    Wong KM, Rubinstein L, Rinker M, Smith GL, Sharon E, Eckhardt SE, Messersmith WA, Leong S, Harris PJ, Gao D, ASCO General Meeting, 1/1/2016
  • Predicting outcomes in patients with advanced malignancies treated on Phase 1 clinical trials.
    Wong KM, Gao D, McCoy H, Brock A, Powell RW, O'Bryant CL, Camidge DR, Gore L, Jimeno A, Diamond JR, Messersmith WA, Eckhardt SG, Leong S, J Clin Oncol, 1/1/2015
  • Phase Ib study of oral dual-PI3K/mTOR inhibitor GDC-0980 in combination with capecitabine and mFOLFOX6+bevacizumab in patients with advanced solid tumors and colorecta...
    Rosen LS, Goldman J, Stewart S, Hubbard JM, Roos M, Capdevila J, Maynes L, Lin W, O'Keeffe B, Lackner M, Spoerke J, Ware J, Arnieri B, Freas E, Leong S, 26th EORTC-NCI-AACR Symposium, Barcelona, Spain, 1/1/2014
  • Join now to see all

Press Mentions

  • Oncologists See Benefit of Medical Marijuana, but Not Comfortable Prescribing
    Oncologists See Benefit of Medical Marijuana, but Not Comfortable PrescribingMay 30th, 2019
  • Suny Downstate Hematology Oncology Fellowship
    Suny Downstate Hematology Oncology FellowshipApril 3rd, 2021

Committees

  • Committee Member, NCCN Esophageal and Gastric Cancer Guidelines 2013 - Present
  • Member, ASCO Connection Editorial Board 2013 - Present
  • Member, NIH Esophageal and Gastric Task Force

Professional Memberships